Archive: May 2010

ChemoVAC: Diabetic Wound Care SALSAtized.

May 21, 2010

ChemoVac Dressing Assembly Video Tutorial As a followup to an older post. There have been many requests to demonstrate this process. This was a little something put together by some members of the SALSA ToeAndFlow team. Enjoy!   For a link to the original post on Chemovac Dressing Assembly: http://diabeticfootonline.blogspot.com/2010/04/step-wise-discussion-of-chemovac.html   Chemotherapy is classically defined as the treatment of disease by use of chemicals. In addition to microbial management of a wound environment, this term has recently become adopted in the…

Read More →

The Foot as a Health Indicator

May 20, 2010

  Foot problems may be warning of heart attack, stroke By Jeffery Boberg, D.P.M Maybe it’s because of my medical specialty — podiatry, the diagnosis and treatment of foot, ankle and lower leg disorders — but it seems everyone I talk to knows someone who has lost a toe, foot or leg to diabetes. In reality, only a small percentage of diabetics lose part of a limb. Diabetes reduces blood circulation and causes nerve damage throughout the entire body. The…

Read More →

Insulin is Good for YOU

May 19, 2010

Insulin Protects Against Artery Damage Long suspected of worsening artery damage in patients with diabetes, insulin instead protects blood vessels, a new study by Joslin Diabetes Center scientists indicates…. For decades, medical researchers have debated whether insulin can promote atherosclerosis, the buildup of cholesterol in blood vessels that causes coronary artery disease and stroke. This was no theoretical argument for those patients with Type 2 diabetes who need insulin injections to control their blood glucose. But now, Joslin researchers have…

Read More →

More on ACCORD

May 19, 2010

Low HbA1c not linked to mortality in new ACCORD analysis   An analysis of mortality in the Action to Control Cardiovascular Disease in Diabetes, or ACCORD, study found that rapidly lowering glucose and maintaining near-normal glucose levels by using an intensive control strategy did not cause higher death rates compared with a standard control strategy, according to a new study in Diabetes Care. “Our findings show that neither a rapid early reduction of glucose, and thus HbA1c, nor a sustained near-normal…

Read More →

ACCORD Results revisited

May 12, 2010

Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial Matthew C. Riddle, MD1, Walter T. Ambrosius, PHD2, David J. Brillon, MD3, John B. Buse, MD, PHD4, Robert P. Byington, MPH, PHD2, Robert M. Cohen, MD5, David C. Goff Jr., MD, PHD2, Saul Malozowski, MD, PHD6, Karen L. Margolis, MD, MPH7, Jeffrey L. Probstfield, MD8, Adrian Schnall, MD9, Elizabeth R. Seaquist, MD10 and for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators*…

Read More →

High Mortality Rate in Diabetics with Charcot Neuroarthropathy

May 7, 2010

Mortality associated with acute charcot foot and neuropathic foot ulceration. van Baal J, Hubbard R, Game F, Jeffcoate W. Foot Ulcer Trials Unit, Nottingham University Hospitals Trust, City Hospital Campus, Nottingham, UK. Abstract OBJECTIVE: To compare the mortality of patients with an acute Charcot foot with a matched population with uninfected neuropathic foot ulcers (NFUs). RESEARCH DESIGN AND METHODS: Data were extracted from a specialist departmental database, supplemented by hospital records. The findings were compared with the results of earlier populations with Charcot…

Read More →